Cystic fibrosis-related diabetes testing in Misano Adriatico
Find health labs to test for Cystic fibrosis-related diabetes in Misano Adriatico and compare all offers by prices and services.
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€35.00
€33.25 with our promocode
See Details
Hemoglobin Test by Analisi Cliniche Emolab Di S.Ciacio & C. S.R.L.
Viale Torquato Tasso, 120, 47838 Riccione RN, Italia
2.6 km
Hemoglobin Test by Poliambulatorio Exis - Centro Medico Fisioterapico e Riabilitativo
Via Roma, 7, 47833 Morciano di Romagna RN, Italia
4.7 km
Hemoglobin Test by Farmacia Donati-Merlini
Viale Giovanni Pascoli, 65, 47923 Rimini RN, Italia
8.8 km
Hemoglobin Test by Centro Igea S. Antimo
Viale degli Oleandri, 38, 48123 Ravenna RA, Italia
39.2 km
Hemoglobin Test by Farmacia Giotti Dr.Roberto
Via Nazionale, 96, 52010 Chiusi della Verna AR, Italia
42.3 km
Diabetes Test by Casa della Salute
Via San Benedetto, 20, 50066 Reggello FI, Italia
61.1 km
Diabetes Test by Delta Implants
Via Pietro Cestellini, 11, 06135 Perugia PG, Italia
61.8 km
Unverified
A Diabetes Test costs €30.00
See Details
Diabetes Test by "Clinilab" Laboratorio Analisi Cliniche
Via Alessandro Manzoni, 418, 06135 Perugia PG, Italia
61.8 km
Verified
A Diabetes Test costs €44.00
See Details
Diabetes Test by PROTOS Centro Diagnostico
Via del Discobolo, 14, 06132 Perugia PG, Italia
61.8 km
Unverified
A Diabetes Test costs €30.00
See Details
Diabetes Test by Crabion S.R.L.
Via Amilcare Ponchielli, 8, 06073 Corciano PG, Italia
61.8 km
Unverified
A Diabetes Test costs €49.00
See Details
Cystic fibrosis-related diabetes - symptoms and how to test
Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.
